Oct. 26 (Bloomberg) -- Litha Healthcare Group Ltd., a pharmaceutical developer and wholesaler, may pay a maiden dividend for the fiscal year through June 2012, according to Financial Director Martin Kahanovitz.
Litha’s board will consider a payment as a “strategic decision” to satisfy institutional investors, Kahanovitz said in an interview with Johannesburg-based Investors Monthly today.
The group is also looking at signing licensing agreements with overseas generic drug manufacturers to register their products in South Africa, he said.
--Editors: Alastair Reed, Hilton Shone.
To contact the reporter on this story: Stephen Gunnion in Johannesburg at email@example.com
To contact the editor responsible for this story: Gavin Serkin at firstname.lastname@example.org